Icosavax announces interim results from IVX-A12 trial
PremiumThe FlyIcosavax announces interim results from IVX-A12 trial
11M ago
Icosavax to be acquired by AstraZeneca for $15.00 per share in cash, CVR
Premium
The Fly
Icosavax to be acquired by AstraZeneca for $15.00 per share in cash, CVR
11M ago
Icosavax initiated with a Buy at Guggenheim
Premium
The Fly
Icosavax initiated with a Buy at Guggenheim
12M ago
Icosavax initiates Phase 2 trial of IVX-A12 against RSV, hMPV
PremiumThe FlyIcosavax initiates Phase 2 trial of IVX-A12 against RSV, hMPV
1y ago
Icosavax reports Q4 EPS (59c), consensus (59c)
Premium
The Fly
Icosavax reports Q4 EPS (59c), consensus (59c)
2y ago
Icosavax, Inc. (ICVX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Icosavax, Inc. (ICVX) Q4 Earnings Cheat Sheet
2y ago
Icosavax initiated with an Outperform at Oppenheimer
PremiumThe FlyIcosavax initiated with an Outperform at Oppenheimer
2y ago
Icosavax reports durability data for VLP vaccine IVX-121 against RSV
Premium
The Fly
Icosavax reports durability data for VLP vaccine IVX-121 against RSV
2y ago
Icosavax reports Q3 EPS (55c), consensus (57c)
Premium
The Fly
Icosavax reports Q3 EPS (55c), consensus (57c)
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100